[
  {
    "ts": null,
    "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of August 24",
    "summary": "Dividend Champion, Contender, And Challenger Highlights: Week Of August 24",
    "url": "https://finnhub.io/api/news?id=f690af61c896f046b572e7a954d2d57a40b46fc083063ba8c71308e9bc4c5601",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755887292,
      "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of August 24",
      "id": 136485520,
      "image": "",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=f690af61c896f046b572e7a954d2d57a40b46fc083063ba8c71308e9bc4c5601"
    }
  },
  {
    "ts": null,
    "headline": "Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now",
    "summary": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",
    "url": "https://finnhub.io/api/news?id=942470b770452e2791a98a5722215f035fc0f266c681381d1e9512266db9c6ef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755877502,
      "headline": "Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now",
      "id": 136478911,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",
      "url": "https://finnhub.io/api/news?id=942470b770452e2791a98a5722215f035fc0f266c681381d1e9512266db9c6ef"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market Today: Stocks surge after Fed's Powell hints on rates",
    "summary": "Plus: How have investors reacted to the Fed Symposium in the past?",
    "url": "https://finnhub.io/api/news?id=cb2f82f0714f19d13f0948218750956d328b55e5955e027dba27bee04581d736",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755873909,
      "headline": "Stock Market Today: Stocks surge after Fed's Powell hints on rates",
      "id": 136496019,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Plus: How have investors reacted to the Fed Symposium in the past?",
      "url": "https://finnhub.io/api/news?id=cb2f82f0714f19d13f0948218750956d328b55e5955e027dba27bee04581d736"
    }
  },
  {
    "ts": null,
    "headline": "Stryker's Robotics and Global Gains Offset by Macro Concerns",
    "summary": "SYK posted strong Q2 growth driven by Mako robotics and global demand, but inflation, FX and competitive pressures temper near-term upside.",
    "url": "https://finnhub.io/api/news?id=bc55357da4cfba3aa413cd58059542d202f6f8e62a4e6ac3b6089934acbdb8a9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755870780,
      "headline": "Stryker's Robotics and Global Gains Offset by Macro Concerns",
      "id": 136477140,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "SYK posted strong Q2 growth driven by Mako robotics and global demand, but inflation, FX and competitive pressures temper near-term upside.",
      "url": "https://finnhub.io/api/news?id=bc55357da4cfba3aa413cd58059542d202f6f8e62a4e6ac3b6089934acbdb8a9"
    }
  },
  {
    "ts": null,
    "headline": "4 Medical Devices Behemoths to Buy Amid Extensive AI Applications",
    "summary": "AI-driven innovations in medical devices are fueling growth for BSX, JNJ, GEHC and TEM.",
    "url": "https://finnhub.io/api/news?id=13d47be7f5a762785df052a19d39065604577832628b694704f86e6decdc3fc6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755864120,
      "headline": "4 Medical Devices Behemoths to Buy Amid Extensive AI Applications",
      "id": 136476644,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "AI-driven innovations in medical devices are fueling growth for BSX, JNJ, GEHC and TEM.",
      "url": "https://finnhub.io/api/news?id=13d47be7f5a762785df052a19d39065604577832628b694704f86e6decdc3fc6"
    }
  },
  {
    "ts": null,
    "headline": "Investors Crave Long-Term Debt, But Firms Don’t Want to Sell",
    "summary": "When blue-chip companies have sold debt maturing in 30 years or more in the US, they’ve found heavy demand, with money managers placing orders equal to about five times the notes for sale on average.  Drugmaker Eli Lilly & Co drew $14.7 billion of orders earlier this week for just $2 billion of 30- and 40-year bonds.  Investors are eager to lock in yields above 5.5%, a relatively high level, especially as money managers enjoy robust inflows and the Federal Reserve gets closer to cutting rates.",
    "url": "https://finnhub.io/api/news?id=5a68ebd2e1f002224dadbac608b50cb7f6df768e90c4de79fe70887b6e682f67",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755864009,
      "headline": "Investors Crave Long-Term Debt, But Firms Don’t Want to Sell",
      "id": 136476603,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "When blue-chip companies have sold debt maturing in 30 years or more in the US, they’ve found heavy demand, with money managers placing orders equal to about five times the notes for sale on average.  Drugmaker Eli Lilly & Co drew $14.7 billion of orders earlier this week for just $2 billion of 30- and 40-year bonds.  Investors are eager to lock in yields above 5.5%, a relatively high level, especially as money managers enjoy robust inflows and the Federal Reserve gets closer to cutting rates.",
      "url": "https://finnhub.io/api/news?id=5a68ebd2e1f002224dadbac608b50cb7f6df768e90c4de79fe70887b6e682f67"
    }
  },
  {
    "ts": null,
    "headline": "BNY Mellon Income Stock Fund Q2 2025 Commentary",
    "summary": "BNY Mellon Income Stock Fund returned 4.52% during the second quarter of 2025. Click here to read more.",
    "url": "https://finnhub.io/api/news?id=23f57fa4f5db9e26acfa435cac2f2e51ea2c778ce0c77e630a64c2e73ef2dea0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755860400,
      "headline": "BNY Mellon Income Stock Fund Q2 2025 Commentary",
      "id": 136476513,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2187991365/image_2187991365.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "BNY Mellon Income Stock Fund returned 4.52% during the second quarter of 2025. Click here to read more.",
      "url": "https://finnhub.io/api/news?id=23f57fa4f5db9e26acfa435cac2f2e51ea2c778ce0c77e630a64c2e73ef2dea0"
    }
  }
]